Neurocrine Biosciences (NBIX) Tops Q1 EPS by 28c, Revenues Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Neurocrine Biosciences Reports First Quarter 2020 Financial Results
May 6, 2020 4:01 PM EDTSAN DIEGO, May 6, 2020 /PRNewswire/ --Â Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2020 and provided revised full-year 2020 financial expense guidance.
"First and foremost, I would... More
